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A 3 kb eDNA coding for rat liver S.adenosylmethionine (AdoMet) synthetase has been isolated, The Mr of the protein has been unequivocally 
determined by eDNA sequencing and enzyme purification on a thiopropyl.Sepharose column. The length of the mRNA 5" non-coding region has 
been defined by primer.extension a alysis. The rat liver cloned eDNA has been also used to detect S-adenosylmethionine synthetase mRNA in 
human liver, 
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1. INTRODUCTION 
S-Adenosylmethionine (AdoMet) synthetase 
(ATP:L-methionine S-adenosyltransrerase, EC 2.5.1.6) 
is the enzyme responsible for the synthesis of AdoMet 
using methionine and ATP as substrates [1,2]. In rat 
liver, two distinct oligomeric forms of the enzyme have 
been identified and designated as high- and low-Mr 
AdoMet synthetases. It has been shown that both forms 
are constituted by the same polypeptide chain, which 
has an apparent molecular mass of 48.5 kDa on polya- 
crylamide gel electrophoresis [3,4]. Recently, Horikawa 
et al. [5] have isolated a 1.8 kb cDNAcoding for rat liver 
AdoMet synthetase. The deduced amino acid sequence 
corresponds toa protein with an Mr of 43.7 kDa instead 
of the 48.5 kDa described for the purified enzyme sub- 
unit. However, as indicated by the authors and since 
they have only sequenced 72 nucleotides upstream the 
proposed ATG initiation codon, the possibility of the 
presence of another translational start site upstream 
from the nucleotide residue -72, that results in a larger 
protein, could not be excluded. 
In an attempt o elucidate the full sequence of the 
protein, we have isolated a 3.0 kb eDNA encoding rat 
liver AdoMet synthetase from a phage lambda gt 11 
library. The sequence of the cDNA completes that 
*l'he nucleotide sequence data reported will appear in the EMBL, 
Genebank and DDBJ Nucleotide sequence Databases under the acces- 
sion number X60822 
Correspondence address." J.M. Mate, Institute de Investigaciones 
Biom~dicas del CSIC, Arturo Duperier 4. Madrid 28029, Spain, Fax: 
(34) (1) 5854015. 
previously reported and unequivocally establishes the 
exact Mr of the protein. Moreover, the Mr deduced from 
the eDNA sequence and that obtained with the enzyme 
purified on a thiopropyl-sepharose column are com- 
pared. 
2. MATERIALS AND METHODS 
Restriction enzymes were obtained either from goehringer 
Mauntleim or Biotech S.L. Reverse transcriptase from avian myelo. 
blastosis virus was purchased from Seikagagn America. Nylon 
membranes were from Schleicher and Sehuell. The sequenase DNA 
sequencing kit was purchased from United States Bioehemieals (CIr. 
veland OH). [~-32P]dCTP, [0~:sS]dATP and [r:2P]ATP were from Du 
Pont-New England Nuclear. Synthetic oligonucleotides were provided 
by Bio.synthesis S.L. Oligo(dT)-cellulose was from Boehringer 
Mannheim. Thiopropyl-sepharose 6B was a product from Phartnacia, 
and L-cysteine was purchased from Aldrich. Lambda gtl l  eDNA 
library was kindly provided by Dr Frank Gonzfilez (National Cancer 
Institute). 
2.1. Library screening and DNA sequence analysis 
Recombinant plaques were screened at a density of 10 000 plaques/ 
100 mm plate using a synthetic oligonucleotide probe of 18 bases 
corresponding toAdoMet synthetase eDNA nucleotide residues +61/ 
+78 [5]. The probe was end-labelled at the 5' end using standard 
procedures [6]. DNA from positive phage was isolated by the plate 
lysate method [6]. The DNA was digested with EcoRI endonuclease 
and the inserts subcloned into the EcoRI site of PUC 18, The insert 
was digested with Haelll, Alul, Sacl, EcoRl and ClaI according to the 
restriction map already described [5], and that shown in Fig. I Se- 
quencing of both strands was performed by the dideoxy chain termina- 
tion method [7]. 
2.2, RNA extraction and Northern analysis 
Total RNA was isolated by the guanidinium thiocyanate method 
[8]. For primer extension analysis, poly(A) ÷ RNA was prepared by 
oligo(dT)-cellulose column chromatography [9]. Aliquots of 25/,/g of 
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Fig. 1. Nucleotide sequence of the 5’ and 3’ regions of pSSRL cDNA. (A) Partial restriction map of pSSRL. Dashed boxes represent he cDNA 
fragments that comprise the sequences hown below. (8) Nucleotide sequence of pSSRL 5’ region, 210 nt of the 5’ untranslated region are shown 
aiang with the first 138 nt of the coding sequence, ATG translational initiation codon is boxed and the TAG termination codon 5’ upstream the 
ATG is upperlined. ‘The sequence of the synthetic oligonucleotide used for the library screening and primer extension analysis is underlined. (C) 
Nucle~tidc sequence of pSSRL 3’ region, Asterisks at positions -72 and -7 1 (in B) and i 756-l 757, 1762-l 766 (in C) mark the points of discrepancy 
with the sequence published by Horikawa et al. [5], as discussed in the text. 
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Fig. 2. Primer extension analysis of the mRNA corresponding to 
pSSRL cDNA. A synthetic primer complementary to nucleotides +61 
to +78 of the AdoMet synthetase sequence was Send “*P-labelled and 
annealed with Poly(A)’ RNA from rat liver (L) and kidney (K). 
Conditions were as described in section 2. 
total RNA were denatured with glyoxal, separated by electrophoresis 
in I .l % agarose gels and transferred to nylon membranes. Prehy- 
bridization and hybridization of the membranes were performed as 
described [IO]. AdoMet synthetase probe (pSSRL) was labelled by 
nick translation to a specific radioactivity of 2 x 10” cpm&g. 
2.3, Printer-extension unalysis 
The primer extension pracedure was performed essentially as pre- 
viously described [I 11. 5 pmol of the end-labelled oligonucleotide men- 
tioned above were annealed to 5 ,ug of poly(A)’ RNA either from rat 
liver or kidney by incubation at 85°C for 5 min and then at 42°C for 
2 h in 0.1 M Tris-HCI buffer at pH 8.3, containing 0.14 M KCI and 
I mM EDTA, The buffer was then adjusted to I mM dNTPs, IS mM 
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dithiotreitol and IO mM M&l,. 25 U of placental ribonucleasc inhib- 
itor and 50 IJ of AMV reverse transcriptase were added. Reverse 
transcription was carried out at 42OC for 90 min. After synthesis, 
nucleic acids were precipitated with ethanol and electrophoresed on 
6% polyacrylamide gels containing 7 M urea. 
2.4. AdoMc~ synthcrase purifcalion on n thiopropyl-sepharose column 
A thiopropyl-sepharose column of 20 ml (12 x 1.5 cm) was prepared 
and equilibrated in IO mM HEPIWNa, 10 mM MgSo,, 1 mM EDTA, 
50 mM KCI pH 8. High-M, AdoMet synthetase (10 mg), purified as 
described by Cabrero et al. [3], was loaded on this column at a flow 
rate of 30 ml/h and 3 ml fractions were collected. The column was then 
washed with 50 ml of the equilibration buffer, followed by another SO 
ml of the same buffer containing 5 mM cysteine. The elution was 
carried out with a 200 ml gradient from 5 mM to 20 mM cysteine in 
the equilibration buffer. AdoMet synthetase activity of all the frac- 
tions was assayed as described previously [3) and a pool of the active 
fractions was made. A sample of this pool was loaded on a 10% 
SDS-polyacrylamide gel under reducing conditions, and the electro- 
phoresis was developed as described by Laemmly el al. [12]. 
3. RESULTS AND DISGUSSIQW 
3.1. Isolation oj” cDiVA coding Jar rat liver AdoMet 
synthetase and primer extension analysis 
A lambda gtll rat liver cDNA library was screened 
with a synthetic oligonucleotide complementary to 61- 
78 nucleotide residues of the AdoMet synthetase cDNA 
sequence previously reported [5]. Out of 200 000 in- 
dependent recombinants, we obtained five positive 
clones which contained inserts ranging in size between 
0.9 and 3.0 kbp. All of them were su,bcloned into WC18 
and the largest one, designated pSSRL, was subjected 
to further analysis. The sequencing strategy of the 
cDNA was performed according to both the reported 
restriction map [SJ and that shown in Fig. 1. The nu- 
cleotide sequence was determined on both strands, A 
sequence comparison between our cloned cDNA 
(pSSRL) and that already published (RLAS) indicates 
that the former is about 1200 bp longer. pSSRL con- 
tains two additional fragments of 138 bp and 1029 bp 
beyond the 5’ and 3’ ends of RLAS respectively. The 
sequences of both fragments are shown in Fig. I. The 
3’ additional extension does not contain the poly(A) tail, 
and no regulatory element has been found. Differences 
between pSSRL and RLAS sequences in the overlap- 
ping region are marked by asterisks. 
The 5 non-coding region of RLAS contains 72 nu- 
cleotides. From nucleotide residue -70, both pSSRL 
and RLAS sequences are identical. However, they differ 
in two bases located at positions -72/-71. Since these 
residues are positioned just.at the 5’ end of RLAS, it 
cannot be excluded that Horikawa’s group have inter- 
preted two nucleotides of the cloning vector as part of 
AdoMet synthetase sequence. As shown in Fig. 1, in the 
pSSRL 5’ non-coding region another ATG start codon 
upstream the putative ATG reported in RLAS has not 
been detected. Moreover, the presence of a TAG trans- 
lational termination codon in the same frame upstream 
from that ATG has been observed (Fig. 1). Therefore, 
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Fig. 4. Northern blot analysis of AdoMet synthetase mitNA in rat 
tissues and in human liver. Total RNA extracted from the tissues listed 
below was hybridized to the pSSRL probe. The RNA sources were: 
liver (A), kidney(B), spleen (C), heart (D), and brain(E) from rat and 
Fig. 3. SDS-polyacrylamide electrophoresis of high-M, AdoMet syn- human liver (F). Lanes A-E of the blot were exposed for autoradio- 
thetase purified on a thiopropyl-sepharose column. 50 /*g of high-M, graphy for one day. The exposition of lane F lasted for 3 days. 
AdoMet synthetase purified on a thiopropyl-sepharose column was 
loaded on a 10% SDS-polyacrylamide electrophoresis gel under reduc- 
ing conditions. The molecular weight standards used were: phos- 
phorylase B (97 400 Da), bovine serum albumin (66 200 Da), oval- 
bumin (45 000 Da), carbonic anhydrase (31 000 Da), soybean trypsin 
inhibitor (21 500 Da) and lysozyme (I4 400 Da). 
the possibility of a larger form of AdoMet. synthetase 
produced by the presence of another translational site 
can be excluded. 
To further delineate the length of the S-untranslated 
sequence ofAdoMet synthetase mRNA, a primer exten- 
sion analysis was carried out. The oligonuclestide 
primer shown underlined in Pig. II was annealed to 
Poly(A)’ RNA isolated from both rat liver and rat 
kidney and was extended towards the 5’ end of the 
corresponding mRNA by reverse transcription. As 
shown in Fig. 2, in the liver sample, the primer extension 
reaction yielded a product of about 350 nt, indicating 
that the 5’ non-coding region of the mRNA is about 270 
nt long. Consequently, pSSRL contains almost the en- 
tire Y-untranslated sequence of AdoMet synthetase 
mEaNA. On the other hand, no fragment was extended 
when Poly(A)’ RNA from kidney was used. A cDNA 
clone for a kidney AdoMet synthetase has been re- 
ported, that in Northern analysis was able to detect 
two mRNA species in this tissue, but did not hybridize 
to the liver RNA [13]. Since the liver and kidney 
AdoMet synthetase cDNA sequences eem to be differ- 
ent, the result obtained with the kidney sample on 
primer ex,tension was expected. The primer extension 
analysis also determines in a precise way the ocsurrence 
of only one mRNA species coding for this protein in rat 
liver and further excludes the possibility of an alterna- 
tive transcriptional initiation site, as has been proposed 
to take place in kidney [13]. 
3.2. AdoMet synthetase purj@cation on a thiopropyi- 
sepharose column 
The results shown above unequivocally establish that 
the molecular mass of AdoMet synthetase is that 
deduced from the cDNA sequence published [5]. How- 
ever, in SDS-PAGE the purified protein shows a larger 
band, of about 48.5 kDa [3]. 
Due to the known importance of AdoMet synthetase 
sulfbydryl groups [14,15] in maintaining the enzyme 
structure and activity, the high-1W; form of the enzyme 
was purified as described in [3], to then be chroma- 
tographed on a thiopropyl-sepharose column. After its 
elution with a cysteine gradient, AdoMet synthetase 
activity was determined (data not shown), the active 
fractions pooled and a sample loaded on a 10% SDS- 
PACE gel under reducing conditions. The molecular 
weight of the protein band obtained by this procedure 
was about 43 kDa (Fig. 3), a result that is consistent 
with the M, deduced from the cDNA sequence. The 
reason for the modification in the electrophoretic be- 
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haviour of the enzyme afte= its chromatography on the 
thiopropyl-sepharose column is not clear, but might be 
related to the role of sulfhydryl groups in maintaining 
the activity and structure of the enzyme [14,15]. 
3.3. Northern blot analysis 
pSSRL was used as a probe for Northern analysis of 
AdoMet synthetase mRNA in various rat tissues and in 
human liver (Fig. 4). In rat, a strong hybridization 
signal corresponding to an mRNA species of about 3.4 
kb was detected only in liver, in agreement with data 
previously reported [5,13] and with primer extension 
results. A single hybridization band of similar size was 
obtained when total RNA from human liver was 
analyzed, although this signal was weaker than that 
observed in RNA samples from rat liver. A high homol- 
ogy between rat and human liver AdoMet synthetase 
mRNA sequences could be expected, since an extensive 
similarity among Escherichia coli, yeast and rat liver 
has also been found [5,16-18]. Thus, this finding indi- 
cates that a rat liver eDNA can be used as a prpbe for 
studies on AdoMet synthetase mRNA regulation in 
human liver. This might be important in view of the 
known alterations in AdoMet metabolism in human 
liver diseases [2,19-21]. 
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